Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lexicon Pharmaceutcl (NQ: LXRX ) 1.220 -0.730 (-37.44%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 20,999,969 Open 1.200 Bid (Size) 1.230 (19) Ask (Size) 1.260 (6) Prev. Close 1.950 Today's Range 1.160 - 1.380 52wk Range 0.9200 - 3.730 Shares Outstanding 144,474,452 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News What You Missed On Wall Street This Past Friday November 03, 2024 Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. Via Talk Markets Crude Oil Moves Higher; Apple Shares Slide After Q4 Results November 01, 2024 Via Benzinga Exposures Fossil Fuels Performance YTD -23.27% -23.27% 1 Month -27.81% -27.81% 3 Month -19.47% -19.47% 6 Month -33.33% -33.33% 1 Year -5.43% -5.43% More News Read More 12 Health Care Stocks Moving In Friday's Intraday Session November 01, 2024 Via Benzinga Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results November 01, 2024 Via Benzinga Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock September 27, 2024 Via Benzinga The Analyst Verdict: Lexicon Pharmaceuticals In The Eyes Of 8 Experts September 03, 2024 Via Benzinga Analyst Scoreboard: 6 Ratings For Lexicon Pharmaceuticals August 13, 2024 Via Benzinga Dow Jumps 400 Points; US Adds 12,000 Jobs In October November 01, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket November 01, 2024 Via Benzinga FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes November 01, 2024 Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's Pre-Market Session November 01, 2024 Via Benzinga 5 Analysts Have This To Say About Lexicon Pharmaceuticals August 02, 2024 Via Benzinga Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings) October 23, 2024 Via Benzinga Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights October 17, 2024 Via Benzinga Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket August 02, 2024 Via Benzinga Intel Reports Weak Results, Joins Amazon, Opendoor Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session August 02, 2024 Via Benzinga Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 17, 2024 Via Benzinga Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday June 17, 2024 Via Benzinga Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day May 13, 2024 Via Investor's Business Daily LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday April 22, 2024 Via Benzinga Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday March 27, 2024 Via Benzinga Topics Stocks Exposures US Equities ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session March 12, 2024 Via Benzinga Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 27, 2024 Via Benzinga Dow Turns Higher; GDS Holdings Shares Climb March 11, 2024 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
